Northwestern Researchers Find Drug That Rejuvenates Neurons to Protect Against Parkinson's Disease

Researchers in Northwestern's Feinberg School of Medicine have identified a promising drug in the treatment of Parkinson's disease.  Parkinson's is one of the most prevalent and devastating neurologic diseases worldwide, affecting more than half a million people in the United States alone, with 50,000 new cases annually. 

The most promising angle of this story is that the drug identified as effective in protecing mice against Parkinson's, isradipine, is already being used in humans to treat high blood pressure and stroke.  A human clinical study is the next step to validate the results found in the mouse.